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These techniques are now also being used to detect and identify Ngonorrhoeae and to analyse the epidemiology ofgonorrhoea. Plasmid and chromosomal mediated antibiotic resistance increases the difficulty of controlling gonorrhoea. Resistant strains occur all over the world and new patterns of resistance are still emerging.
A better understanding of gonococcal pathogenicity is necessary for the development of an effective vaccine. Despite work on pili and outer membrane proteins no vaccine yet exists. The control of gonorrhoea still depends on diagnosis, treatment, and epidemiological control, facilities that are not widely available in many of those parts of the world where gonorrhoea is a major problem.
Diagnosis of Neisseria gonorrhoeae
Culture of the causative organism Neisseria gonorrhoeae remains the gold standard for the diagnosis of gonorrhoea for two reasons: the sensitivity of culture, although probably not 100%, is higher with other techniques; and the development of antibiotic resistance requires that in vitro susceptibility tests be performed.
Sensitivity of culture depends on the quality of the specimen. The ideal procedure is to take the specimen from the patient and culture directly on to selective medium. If incubated immediately at 36'C in 5-7% carbon dioxide this produces the highest isolation rate. When this is not possible, a transport medium such as the buffered media of Stuart and Amies is adequate, if the swab transferred to selective media within six to eight hours.
The design of a suitable medium for the growth of Ngonorrhoeae from clinical specimens must include sufficient nutrients for this fastidious organism and antibiotics to suppress the growth of normal flora particularly from the rectum and pharynx which will also be present.
Gonococci have an absolute requirement for cysteine and iron and the only carbohydrate they use is glucose. In some media these requirements are met by the addition of blood, often chocolatised, or haemoglobin to a GC agar base containing peptones and starch, but in others supplements such as Kellogg's' or IsoVitalex (BBL) without any blood products are used. The choice of an antibiotic cocktail to suppress normal flora is difficult because in some instances gonococci will also be inhibited. The most popular combination includes vancomycin (3 mg/l), which inhibits Gram positive bacteria; colistin (7-5 mg/1), which is active against Gram negative rods; and trimethoprim (5 mg/l), which prevents the swarming of Proteus sp. Nystatin (12 500 y/1) or amphotericin (1-5 mg/l) is also added to inhibit yeasts.
Colistin and trimethoprim are only slightly toxic to gonococci at the concentrations used, but some strains of Ngonorrhoeae (env mutants) are sensitive to vancomycin. The prevalence of these strains varies but has been reported to be as high as 30%.2 Lincomycin has been suggested as an alternative to vancomycin,3 but in our experience results in overgrowth of other flora, which prevents the detection of more, strains of gonococci than would have been missed due to the addition of vancomycin.
In many laboratories both selective and nonselective media are used, and this overcomes the problem particularly with male urethral samples that are not heavily contaminated with normal flora. The two selective media commonly used are a modified Thayer-Martin medium4 and New York City medium.5 For research studies it is often necessary to distinguish between colonial types, and for this a clear medium is required: GC agar base with the addition of Kellogg's defined supplement or IsoVitalex is used. 088
Neisseria gonorrhoeae: a versatile pathogen We have added antibiotics to this medium and use it to isolate gonococci from clinical specimens. We found over a 10 year period that it gives an equal or higher number of positive results. Gonococci grow quickly on this medium and culture on it gives a faster result for patients heavily infected with this organism and a higher isolation rate for patients infected with relatively few organisms. Media for the determination of nutritional requirements6 and opaque and transparent colonies7 have also been used, but rarely in clinical laboratories.
The correct identification of gonococci can be essential for legal reasons. Presumptive identification can be made by the presence of typical colonies (that may change on different media) that are oxidase positive Gram negative diplococci. These colonies can be confirmed to be Ngonorrhoeae by various methods, but carbohydrate utilisation tests are still the most commonly accepted. Either solid media, which require overnight incubation, or liquid media, which can be read within four hours, can be used. Serum sugar slopes have largely been replaced by either cystine tryptophan agar (CTA), or GC agar base8 as the solid medium with glucose, maltose, lactose and sucrose added (1-2% final concentration) and phenol red as a pH indicator. It is important to use highly purified maltose not contaminated with glucose, or erroneous results may be obtained. These media can be used as stabs, slopes, or in Petri dishes, but all require at least 18-24 hours' incubation before reading. The presence of carbon dioxide changes the pH of the medium and therefore they should be incubated without carbon dioxide or left on the bench for 30 minutes before reading.
All rapid methods for carbohydrate degradation are modifications of the principle developed by Kellogg and Turner in 1973.9 Small volumes of buffered carbohydrates containing phenol red indicator are incubated with a heavy inoculum of the culture and can give a result in as little as 15-30 minutes, although incubation for up to four hours is recommended.
Carbohydrate utilisation tests are the accepted method for identification, but differentiation between the species of Neisseria in many cases depends only on the use of a single carbohydrate-maltose distinguishes between Ngonorrhoeae and Nmeningitidis. Several methods have been developed recently to produce either a more rapid or more accurate identification. Fluorescence antibody tests can be used but commercially available reagents using polyclonal antibodies have not been found to be fully specific; false positive fluorescence being shown by some strains of Nlactamica and Nmeningitidis. The inclusion of monoclonal antibodies'0 in such reagents (GC Microtrak; Syva, USA) has resulted in greater specificity and sensitivity. This rapid and simple tech-1089 nique may therefore be used more widely in the future.
Coagglutination reagents using both polyclonal and monoclonal antibodies for the identification of gonococci are available." The principle on which they work is that staphylococci rich in protein A bind immunoglobin G subclasses 1, 2, and 4 nonspecifically by the Fc portion. In the test, staphylococci coated with specific monoclonal gonococcal antibodies are mixed with a boiled suspension of the gonococci under test, and if positive, give visible agglutination. Polyclonal antibodies raised in rabbits gave similar specificity problems as with the immunofluorescence test, but the monoclonal reagent has both a high sensitivity (97%) and a high specificity (97% 14 but we have found it to be less reliable for the identification of non-pathogenic strains. The presence of glutamyl aminopeptidase activity in meningococci has been found useful '5 16 and can aid the identification of maltose negative meningococci. Recently, kits detecting preformed enzymes have become available, some of which also identify Haemophilus. Results are obtained within four hours and are compared with identification profiles stored in a database. The final choice of a gonococcal identification system will be influenced not only by the efficiency of the test but also by the cost and workload of isolates.
The methods for diagnosis of gonorrhoea described above needs two to three days to achieve. In many clinics, however, particularly in large cities with transient populations, it would be advantageous to diagnose and treat gonorrhoea at the patient's first visit. In men with urethral discharge the Gram stain has been used to diagnose gonorrhoea for many years and gives a sensitivity of >98% compared with that of culture. 17 -19 Other antigen detection systems such as enzyme linked assays (Abbott Laboratories), '8 -22 immunofluorescence (Syva),23 and DNA probes24
can equal the sensitivity in this population but are more complex, time consuming, and expensive.
The Gram stain, however, rarely gives a higher sensitivity than 40-50% in women, in whom The evaluation of the Gonozyme ELISA method in women has also shown a noticeable improvement over Gram staining in the sensitivity (78-100%), but the specificity has been found to be variable (70-100%). [18] [19] [20] [21] [22] The number of false positive results that this would produce, particularly in low prevalence populations,22 has led to concern and consequently limited the use of the test.
The potential for monoclonal antibodies to provide the sensitivity and specificity needed in a direct rapid test for gonorrhoea should encourage the evolution of antigen detection systems in the next few years. Cost will, however, remain an important factor, particularly where levels of antibiotic resistance make culture of the organism necessary for sensitivity testing.
Typing and epidemiology
Good reproducible typing systems with sufficient discrimination are essential for effective epidemiological work on bacterial infections. In this, as in so many other aspects, the gonococcus has provided a formidable challenge. Standard Neisseria gonorrhoeae: a versatile pathogen system can be used in conjunction with auxotyping, giving further division into auxotype/serovar (A/S) classes. The use of two stable and genetically distinct characteristics enhances this discrimination.
Thus over seven years gonococcal serology has progressed from a simple polyclonal system with poor discrimination to a highly developed monoclonal system, which for the first time has the potential for detailed epidemiological use. Despite the limited discrimination of the polyclonal WI WII/III system Bygdeman et al were able to use it to examine epidemiological patterns of gonococcal disease and associations between serology and antibiotic resistance.32 33 Until recently, the monoclonal reagents needed for this typing system have not been generally available. Arrangements have now been made for their distribution to interested laboratories. The coagglutination system used is simple and sensitive, protein I types are stable, and the system is reproducible and provides good discrimination. Likely applications are the study of collections of strains from different parts of the world, temporal changes in strains from a particular area, the distinction between treatment failures and reinfection, and the use in forensic cases of sexual abuse.
Although auxotyping and serotyping, backed up in some cases by plasmid analysis, are likely to be the main methods of gonococcal typing in the future, another approach has been tried. Plant and animal lectins recognise specific carbohydrate structures on the bacterial surface. Patterns of lectin agglutination can be used to differentiate between bacterial species and bacterial strains within a species. Such patterns have been used to type gonococci.34 There seems to be a good correlation between this method and gonococcal serology, though whether it offers anything more than serology remains to be seen.
Antibiotic resistance
Very early in the development of penicillin during the Second World War, its efficacy against gonorrhoea was exploited. Venereal diseases such as gonorrhoea were considered to be a major problem by army authorities, and penicillin was soon being used to treat gonorrhoea, as well as more serious wound infections. Since then the widespread use and abuse of ,B lactam producing agents and other antibiotics, combined with increasing ease of global travel, have stimulated and facilitated the development and dissemination of antibiotic resistant gonococci.
Gonococci are naturally sensitive not only to penicillin (minimum inhibitory concentration (MIC) of <006 mg/l), but also to tetracycline. By 1958
Reyn, Horner, and Bentzon3s were able to show an increase in resistance to penicillin in some strains of 1091 over 20 times that of 1944 levels. In some parts of the world, notably the Far East and Africa, this increase in resistance to penicillin developed rapidly. Keys, Halveson, and Clarke36 found 74% of Far Eastern gonococci to have reduced sensitivity to penicillin (MIC > 0-06 mg/1), while Arya and Phillips37 reported similar levels of penicillin resistance in gonococci from Uganda. In contrast, few strains isolated in Europe or North America at this time showed this trend.
CHROMOSOMALLY MEDIATED GONOCOCCAL RESISTANCE
The rate at which penicillin MICs increased in this form of resistance was slow and could be countered by increasing the dose of penicillin or ampicillin and by adding probenecid. Nevertheless, by the early 1970s gonococcal strains with MICs of > 1l0 mg/l that were resistant to penicillin were being found in the Far East. Antibiotic misuse, prostitution, and local wars with large numbers of servicemen in the area were all responsible. Resistant strains were exported to Europe and the United States by servicemen and business travellers. Until recently, however, these did not constitute a major problem outside the Far East.
Up to 1976 gonococcal resistance to antibiotics was exclusively chromosomally controlled (chromosomally mediated resistant Neisseria gonorrhoeae or CMRNG). The mechanism of resistance in CMRNG has been studied mainly by Cannon et al. 38 Mutations at various loci on the gonococcal chromosome each produce small increments in resistance to agents such as penicillin, tetracycline, and chloramphenicol. Mutations at some loci are specific for resistance to a particular antibiotic (pen A for penicillin). At other loci (pen B, mtr) mutations result in non-specific increases in resistance to a range of antibiotics (penicillin, tetracycline, erythromycin, chloramphenicol) and hydrophobic molecules. Strains with clinically important levels of penicillin resistance (>I 0 mg/I) contain multiple mutations and almost invariably show reduced sensitivity to other antibiotics. This whole area has recently been well reviewed by Sparling and Cannon.38 Spectinomycin is an antibiotic with excellent activity against penicillin sensitive and resistant gonococci. In common with streptomycin, resistance to spectinomycin in the gonococcus is controlled by the chromosome. Mutations giving rise to spectinomycin resistance have been described in strains isolated from the Philippines, the United Kingdom, and Korea.39 40 At present spectinomycin resistance does not seem to pose a major clinical problem. Given the value of spectinomycin for treating penicillin resistant gonococci, however, it is important to monitor this where spectinomycin is being used extensively. 44 An increase in infections caused by CMRNG presents several practical problems. First, there is no simple rapid way of detecting CMRNG, short of quantitative sensitivity tests. Second, antibiotics active against PPNG may not necessarily be effective against CMRNG. With these strains, there does seem to be some cross resistance between penicillin and cephalosporins and cephamycins such as cefuroxime and cefoxitin. It remains to be seen whether this will affect the more active f lactam producing agents such as cefotaxime and ceftriaxone. Similarly, antibiotic combinations containing amoxycillin or ampicillin with a P lactamase inhibitor such as clavulanic acid or sulbactam will be ineffective against CMRNG.
CMRNG do seem to have certain characteristic biological features. Serologically their outer membrane protein I is of the IB (WII/Ill) group, while the proline requiring (Pro -) auxotype is also predominant.4345 Characterisation of CMRNG from various parts of the world using the serovar test with the more specific and discriminating single monoclonal reagents now available needs to be done. The precise clinical importance of these associations is still not clear, but it is an important area for future work.
In considering chromosomal control of antibiotic resistance in the gonococcus, there is one peculiarity that could be of clinical importance. Mutations at the mtr locus can result in non-specific antibiotic resistance. A further mutation at the env locus (which normally occurs in mtr containing strains) results in hypersensitivity to a range of antibiotics. 44 It is still not certain whether this check is a temporary phenomenon or whether the rise in the prevalence of PPNG infections in Britain is over. In other European countries, notably the Netherlands, there were similar sharp rises in prevalence of PPNG. There the predominant strains carried the 3-2 MD plasmid.
In the United States prevalence of PPNG also rose sharply, with endemic foci in many large cities. In Neisseria gonorrhoeae: a versatile pathogen Miami during three months in 1986, PPNG accounted for half of all reported cases of gonorrhoea. 54 In the Far East such levels were already common. PPNG has not been a serious problem in homosexual men. 55 The speed with which this type of gonococcal resistance to penicillin has spread illustrates the tremendous potential for spread of plasmid mediated, as opposed to chromosomally mediated, resistance. In 1985 a new phenomenon of high level plasmid mediated resistance to tetracycline was described; strains had MICs of > 16 mg/I. These strains contain a 25-2MD plasmid coding for tetracycline resistance, which probably arose as a recombinant between the 24-5 MD conjugal plasmid and the tet M determinant from streptococci. This determinant has been found in other genital tract species.54 The 25-2 MD plasmid can be transferred to sensitive strains either by transformation or conjugation. The true prevalence of these strains in the United States is unknown. There are as yet no reports of similar strains elsewhere in the world. We have screened several hundred strains of gonococci for high level resistance to tetracycline but have found none. Although tetracycline has been used extensively for the treatment of gonorrhoea, increasing low level resistance, particularly among the serogroup lB strains common in the Far East, has limited its usefulness. It remains, however, the antibiotic of choice for other common genital tract pathogens such as Chlamydia trachomatis. Even if not used to treat gonorrhoea, tetracyline clearly can still exert a strong influence over a wide range of genital organisms.
The gonococcus presents a continuous challenge to the continued use of 0 lactam producing antibiotics including the new cephalosporins, to tetracycline, erythromycin, and chloramphenicol, and to a lesser degree, spectinomycin. CMRNG is difficult to monitor. Tetracycline resistance and spectinomycin resistance of the high level type present similar difficulties in screening and detection. Even with new highly promising agents such as the quinolones there is already at least one report of gonococcal resistance. As far as chemotherapy is concerned the gonococcus continues to present a substantial challenge.
Pathogenicity
Ngonorrhoeae primarily infects the mucosa of the lower genital tract-the urethra in men, and the endocervix in women. Infection of the rectum and pharynx, however, also occurs, particularly in homosexual men, while conjunctival infections occur mainly in neonates. In a few patients complicated or disseminated gonococcal infection can develop, and present 1093 with salpingitis, bacteriaemia, or arthritis. Sterility and ectopic pregnancy are long term sequelae of salpingitis, particularly in those parts of the world where treatment is inadequate or unavailable.
Gonorrhoea remains a major cause of sexually transmitted infections, even in those countries that can provide good chemotherapy and have resources for contact tracing. The gonococcus is a highly adapted pathogen that has acquired or developed antibiotic resistance and which has surface structures that can undergo phase and antigenic variation.56 Both mechanisms ensure the continuing high prevalence of gonorrhoea. The failure of current control measures has resulted in considerable interest and research into a gonococcal vaccine as an alternative to or supplement for chemotherapy, to be used mainly in high risk populations. It was recommended by a National Institutes of Health panel57 that such a vaccine should be directed at the prevention of pelvic inflammatory disease, with mucosal immunity in men a secondary aim. An understanding of the pathogenesis and immunology of gonococcal infection is an essential step in choosing a candidate for a vaccine. Over the past decade this need has stimulated a considerable amount of study into the basic mechanisms of gonococcal host interactions at mucosal surfaces.
Infection by gonococci has been shown to occur in two phases. First, attachment to the mucosa, and second, invasion of the epithelial cell. The initial step of attachment is that the gonococcus and epithelial cell are brought into close proximity. Both bacterial and host cell are negatively charged, and non-specific factors such as pH, surface charge, and hydrophobic interactions may be important in achieving the association. These factors have been reviewed extensively by Watt and Ward.58 Specific gonococcal surfaces structures, primarily pili, and the outer membrane protein PII then mediate attachment to the epithelial cell. In human fallopian tube culture the gonococci attach to non-ciliated epithelial cells. 59 The ciliated cells are damaged, which may be due to the toxic effects of gonococcal lipopolysaccharide60 and slough off. After attachment the gonococci appear to be taken into the cell, where they multiply and are eventually excreted into the lamina propria, setting up infection. This apparent endocytosis of gonococci may be mediated by the outer membrane protein PI.
The outer membrane of the gonococcus is exposed to the environment and the host's immune response and carries the major virulence factors. Its structure is similar to many other Gram negative organisms in that it consists of a phospholipid bilayer that is attached on the inside to a thin layer of peptidoglycan. Embedded in the membrane are proteins (of which there are three major proteins) and lipopolysaccharide. Pili extend from the outer membrane. Pili are associated with the distinctive colonial types (1 and 2) , new clinical isolates, and the ability to infect male volunteers.65 66 Non-piliated colonies occur with repeated subculture and produce colony types (3 and 4), which are less infective. The switch from piliated (P+) to non-piliated (P-) occurs with high frequency, but the reverse, P-to P+, occurs less frequently (phase variation). Pili also exhibit antigenic variation; up to eight antigenically different pili have been isolated from a single strain.67 68 Expression of different types of pili may be forced in vivo to enable the gonococcus to evade the host's immune response, but there is also some in vitro evidence that they confer specificity for different mucosal surfaces. 69 Functional and antigenic domains of gonococcal pili have been determined and show that the fragment containing the amino acid sequence which mediates adherence is highly conserved and common between different isolates.70 The sequence responsible for antigenic variation, however, is normally immunodominant. Despite a detailed knowledge of pilus structure and function a successful vaccine has yet to be produced. A clinical trial in which purified pili from a single strain was given parenterally failed to protect a large number of men.71 Antibody was produced in these men but presumably was not specific for the conserved part of the molecule. Recent work has shown that synthetic peptides spanning common, normally immunorecessive regions of the pilus, will produce polyclonal antibody that can inhibit attachment of both homologous and heterologous gonococci to epithelial cells in vitro.72 This finding suggests that a vaccine to a common pilin peptide might be effective.
OUTER MEMBRANE PROTEINS (OMP)
Protein I is the most dominant of the outer membrane proteins and is present in all strains. For this reason it has been the second candidate for a vaccine and has been used in a small number of studies. It remains of interest because Buchanan et The expression of the outer membrane protein PII has been shown to enhance the attachment of gonococci to epithelial cells in vitro and for this reason has stimulated much interest in recent years. Protein II is a family of heat modifiable proteins with apparent subunit molecular weight between 24-32 000 daltons.75 A single strain of gonococci can express none to six different PIIs, each of which is antigenically distinct. Expression of PII is subject to both phase and antigenic variation.56 In contrast to pili, PIT shows high frequency switching between PII + and PIT -in both directions. The presence of PII has been associated with opaque colonies, and its absence with transparent ones. Colonies isolated from uncomplicated infection in men and from the endocervix at certain times of the menstrual cycle are opaque, whereas colonies isolated from disseminated infection and the endocervix during menstruation are transparent. 76 77 The inference from these observations is that the lack of expression of PIT in some way facilitates invasion to cause systemic disease. The antigenic diversity shown by this family of proteins could help the gonococcus to evade the immune response. Different PITs were detected in serial isolates of contact pairs78 and from an epidemic caused by a single strain. 79 This suggests that again the gonococcus is adapted to a hostile environment by producing different antigenic variants. Another possibility is that individual PIT species exhibit the ability to adhere to different mucosal surfaces80 and hence may enable gonococci to survive in a number of environments within the host. Although PIT has been associated with adherence, susceptibility to killing by normal human serum, and interaction with polymorphs, its antigenic diversity has limited its potential as a candidate for vaccine. The unique peptides of Pll are surface exposed and immunogenic, but although PIls from different strains share many common peptides, they are believed to be buried in the gonococcal membrane.8" If this region of the molecule could be shown to produce antibody in the host which will interfere with part of the infective process it might be given more serious consideration as a candidate for a vaccine.
IgAl protease
IgA protease is an enzyme produced by the pathogenic neisseriae Ngonorrhoeae and Nmeningitidis, but not commensal neisseriae. Its function is to split antibodies of the IgAl subclass, and is therefore believed to be a virulence determinant. Although its role in the pathogenesis of gonorrhoea is still unconfirmed, it remains a potential candidate, to be used probably in conjunction with a pilus or protein I vaccine.
Despite the failure of current clinical trials the search for a vaccine continues. The ideal candidate would have conserved antigenic components common to all gonococci. Protein III is an outer membrane protein found in all strains tested, and peptide mapping has shown that its structure is conserved.82 Cannon etal83 also detected an antigen, H8, which is found in pathogenic but not in commensal neisseriae. Interest now focuses on proteins that are expressed by phenotypes influenced by the growth environment, some of which may be present in vivo. Proteins expressed under iron limiting84 85 and anaerobic conditions86 have been shown to be expressed immunogenically in gonococcal infections.
Conclusions
In the past 10 years we have seen the appearance of PPNG and the establishment of CMRNG in new parts of the world. Much progress has been made in understanding the biology and pathogenicity of the organism, but we still have no vaccine, but the new antibiotics that can treat and help control gonorrhoea are expensive and may therefore not be widely available in many parts of Asia and Africa where infection is rife.
Against this, new antibiotics have been developed with good activity against gonococci. A potentially good typing system is now available, which may allow epidemiological studies to be done with a good microbiological base. Controlling the spread of resistant organisms requires good epidemiology as well as effective antibiotics. Rapid identification systems, particularly for detecting gonorrhoea in women, are now a real possibility, and we have a range of identification systems.
There has been real progress, but the versatility of the gonococcus is likely to prove a continuing challenge for both basic and clinical research workers.
